# Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI

> **NCT00883727** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stempeutics Research Pvt Ltd** · enrollment: 20 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Stem cell
- **DRUG:** Plasmalyte A

## Key facts

- **NCT ID:** NCT00883727
- **Lead sponsor:** Stempeutics Research Pvt Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-05
- **Final completion:** 2012-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883727, "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00883727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*